INTERNATIONAL PATENT: IPSEN BIOPHARM LIMITED FILES APPLICATION FOR "USE OF CHIMERIC BOTULINUM TOXIN A FOR TREATING BLEPHAROSPASM AND HEMIFACIAL SPASM"

GENEVA, May 12 -- IPSEN BIOPHARM LIMITED (Unit 9, Ash RoadWrexham Industrial EstateWrexham LL13 9UF) filed a patent application (PCT/GB2023/052855) for "USE OF CHIMERIC BOTULINUM TOXIN A FOR TREATING BLEPHAROSPASM AND HEMIFACIAL SPASM" on Nov 01, 2023. With publication no. WO/2025/093844, the details related to the patent application was published on May 08, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): PONS, Laurent (c/o Ipsen Biopharm LimitedUnit 9, Ash RoadWrexham Industrial EstateWrexham LL13 9UF), GRIGORE, Nicolae (c/o Ipsen Biopharm LimitedUnit 9, Ash RoadWrexham Industrial EstateWre...